Natco Pharma introduces anti-blood clot tablet in India
Natco Pharma introduces anti-blood clot tablet in India

Natco Pharma introduces anti-blood clot tablet in India

DSIJ Intelligence Article rating: 2.8

Natco Pharma today announced the launch of the Rivaroxaban molecule, under the brand RPIGAT. Rivaroxaban is an anticoagulant medication, which is used to treat as well as prevent blood clots.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.2

The market opened in green on December 17, 2020, overall volumes in futures & options currently stand at 3,01,10,678 contracts with a turnover of Rs. 25,87,753.33 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 3.2

The market opened in green on December 17, 2020, overall volumes in futures & options currently stand at 3,01,10,678 contracts with a turnover of Rs. 25,87,753.33 crore.

Stocks witnessing selling pressure in November 2020
Stocks witnessing selling pressure in November 2020

Stocks witnessing selling pressure in November 2020

DSIJ Intelligence Article rating: 4.1

As every coin has a flip side, mutual funds are no different in that sense. Fund managers not only buy but also sell. It becomes equally important to know what they are selling. So, let’s find out.

Lupin settles Gavis/Novel dispute on a friendly note
Lupin settles Gavis/Novel dispute on a friendly note

Lupin settles Gavis/Novel dispute on a friendly note

DSIJ Intelligence Article rating: 4.7

Lupin has officially announced that the dispute with the sellers of Gavis Pharmaceuticals and Novel Laboratories regarding the breaching of the terms of purchase & sales agreement of the definitive agreement entered in 2015 by the company has now been resolved on a friendly note.

Markets may open on a soft note; follow stock-specific approach in todays session
Markets may open on a soft note; follow stock-specific approach in todays session

Markets may open on a soft note; follow stock-specific approach in todays session

DSIJ Intelligence Article rating: 4.3

On Wednesday, Indian markets displayed a strong performance as Nifty witnessed a breakout of the consolidation range while the key benchmark indices ended the day at record highs. However, on Thursday morning, SGX Nifty is indicating a soft opening as the global cues are not encouraging. SGX Nifty was trading down by 17 points at 13,668 levels.

RSS
First25512552255325542556255825592560Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR